Advertisement

Ads Placeholder
Loading...

MoonLake Immunotherapeutics

MLTX•NASDAQ
Healthcare
Biotechnology
$17.36
$0.84(5.08%)
U.S. Market opens in 63h 8m

MoonLake Immunotherapeutics (MLTX) Stock Overview

Explore MoonLake Immunotherapeutics’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-4.92
EPS (TTM)$-3.53
ROE-0.67%
Fundamental Analysis

AI Price Forecasts

1 Month$16.60
3 Months$1.58
1 Year Target$18.47

MLTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MoonLake Immunotherapeutics (MLTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $18.47.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.92 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.08%
5-Day Change
-1.81%
1-Month Change
-1.87%
3-Month Change
45.27%
6-Month Change
105.93%
Year-to-Date (YTD) Change
45.27%
1-Year Change
-54.39%
3-Year Change
-15.81%
5-Year Change
68.54%
All-Time (Max) Change
65.49%

Contact Information

https://www.moonlaketx.com
41 415108022
Dorfstrasse 29, Zug, NaN, 6300

Company Facts

1,000 Employees
IPO DateOct 20, 2020
CountryCH
Actively Trading

Frequently Asked Questions